Penn Mental Health AIDS Research Center
宾夕法尼亚州心理健康艾滋病研究中心
基本信息
- 批准号:10819857
- 负责人:
- 金额:$ 24.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAccident and Emergency departmentAcquired Immunodeficiency SyndromeAddressAffectAreaBehaviorCOVID-19 pandemicCaringCitiesClientClinicalCluster AnalysisCocaineCommunitiesComprehensive Health CareCounselingCoupledDataDetectionDevelopmentDiagnosisEnvironmentEpidemicEquipmentEquityEvaluationFaceFeedbackFentanylFrightFundingGeographic LocationsHIVHIV diagnosisHealthHealth PersonnelHealth PrioritiesHealth Service AreaHealthcareHeightHeroinHuman immunodeficiency virus testIncidenceInjecting drug userInjectionsIntegrated Delivery of Health CareLegalLinkMental HealthMethamphetamineMethodologyNeedlesNeighborhoodsNewly DiagnosedParticipantPatient EducationPerceptionPersonsPharmaceutical PreparationsPhiladelphiaPreventionProviderPublic HealthRecording of previous eventsResearchRiskService delivery modelService provisionServicesSiteSocial WorkSpace-Time ClusteringSurveysSystemTrainingTraumaUnited States National Institutes of HealthUnsafe Sexcommunity organizationscommunity partnershipcoronavirus diseasecostexperiencehealth care serviceinfection rateinjection drug useinnovationinterestmeetingsoperationoutpatient programsoutreachpreferenceprescription opioidprevention serviceresponsescale upservice organizationservice providerssocial stigmasubstance use treatmentsuccesstesting servicestransmission processtreatment centerwillingness
项目摘要
Project Summary/Abstract
People
incidence
who inject drugs (PWID) are disproportionately affected by HIV incidence in Philadelphia. The HIV
in Philadelphia is growing and returning to pre-COVID pandemic levels.At present, the city health
department's Department of HIV Health funds many community and clinical health providers for HIV testing and
counseling services, including HIV Service Organizations (HSOs), substance use treatment centers, and
emergency departments, which have facilitated the detection of many new cases among PWID in Philadelphia.
Despite these successes, increasing infection rates in PWID suggest a need for scaled-up detection and linkage
strategies. Reliance on traditional HIV prevention providers may yield missed opportunities for HIV diagnoses,
timely linkage-to-care, and cluster detection and response. Leveraging providers in healthcare and social service
environments outside of traditional HIV prevention settings in neighborhoods with high rates of IDU may
maximize opportunities for expanding efforts for HIV cluster detection and response. The extent to which
nonclinical HSO-alternative service providers in these areas understand IDU as a significant contributor to the
HIV epidemic, routinely conduct or refer PWID high-quality HIV testing services, and are willing and capable to
integrate or scale-up HIV testing services within current clinical operations at their agency is poorly understood.
To address these gaps, we propose a 2-year study to conduct the following aims: (Aim 1) Employ persons with
lived experiences/histories of IDU to conduct secret shopper methodologies toward understanding the current
HIV testing/referral practices in nonclinical HSO-alternative outpatient service facilities (N = 15) in Philadelphia
neighborhoods with high IDU; (Aim 2) Deploy surveys with N = 100 PWID living without HIV to evaluate
environmental preferences for HIV prevention services in nonclinical HSO-alternative outpatient service facilities
in Philadelphia; and (Aim 3) Engage with representatives from secret shopper-evaluated facilities through
stakeholder meetings to discuss secret shopper feedback, their perceptions of the HIV epidemic among PWID
in their service area, and their capacity for HIV prevention services. The proposed study will facilitate local
priorities pertaining to the Diagnose pillar of the Ending the HIV Epidemic Initiative and support the city health
department's HIV cluster detection and response strategies. Leveraging HSO-alternative providers' capacities
to conduct, refer, and coordinate HIV testing will maximize equitable access to HIV prevention for PWID and
opportunities to identify new HIV cases and unidentified clusters missed via traditional HIV testing environments,
like HSOs.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly L Jordan-Sciutto其他文献
Kelly L Jordan-Sciutto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly L Jordan-Sciutto', 18)}}的其他基金
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
大麻素、HIV 和 ART 对中枢神经系统的细胞间和细胞内影响
- 批准号:
10452486 - 财政年份:2020
- 资助金额:
$ 24.38万 - 项目类别:
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
大麻素、HIV 和 ART 对中枢神经系统的细胞间和细胞内影响
- 批准号:
10618933 - 财政年份:2020
- 资助金额:
$ 24.38万 - 项目类别:
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
PERK 单倍型在 HIV 相关神经认知障碍中的作用
- 批准号:
9317357 - 财政年份:2016
- 资助金额:
$ 24.38万 - 项目类别:
RNA:RNA binding protein complexes in neurons and SIV encephalitis
RNA:神经元和 SIV 脑炎中的 RNA 结合蛋白复合物
- 批准号:
8937093 - 财政年份:2015
- 资助金额:
$ 24.38万 - 项目类别:
Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous System
HAART介导中枢神经系统神经元毒性的新途径
- 批准号:
7492484 - 财政年份:2009
- 资助金额:
$ 24.38万 - 项目类别:
Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous System
HAART介导中枢神经系统神经元毒性的新途径
- 批准号:
7826669 - 财政年份:2009
- 资助金额:
$ 24.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7417736 - 财政年份:2007
- 资助金额:
$ 24.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7900322 - 财政年份:2007
- 资助金额:
$ 24.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7661396 - 财政年份:2007
- 资助金额:
$ 24.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
8115124 - 财政年份:2007
- 资助金额:
$ 24.38万 - 项目类别: